Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda

The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...

source https://www.ndtv.com/india-news/drug-controller-general-of-india-dgci-approves-commercial-launch-of-low-cost-covid-19-test-feluda-2298124